Keyphrases
5-year Survival
20%
90-day Mortality
18%
Anastomosis Leak
11%
Anastomotic Leak
30%
Antecolic
11%
CD4 T Cells
11%
Cohort Profile
22%
Comorbidity
16%
Confidence Interval
24%
Consensus Group
14%
Delayed Emptying
11%
Distal Gastrectomy
13%
Duodenal Stenting
11%
Esophageal Cancer
49%
Esophageal Complications
14%
Esophageal Stenting
11%
Esophagectomy
28%
Esophagogastric Cancer
33%
Finland
100%
Gastrectomy
62%
Gastric Adenocarcinoma
28%
Gastric Cancer
67%
Gastric Cancer Surgery
13%
Gastric Outlet Obstruction
11%
Gastrojejunostomy
11%
Hand-sewn Anastomosis
11%
Hazard Ratio
15%
Hemoglobin Count
11%
Incidence of Complication
11%
Long-term Survival
12%
Major Complications
11%
National Cohort Study
29%
Neoadjuvant Chemotherapy
11%
Neoadjuvant Therapy
19%
Obesity
11%
Odds Ratio
12%
Palliative Treatment
11%
Population-based
96%
Population-based Study
54%
Post-esophagectomy
22%
Postoperative Complications
49%
Preoperative Hemoglobin
11%
Reoperation
17%
Retrocolic Reconstruction
11%
Retrospective Survey
11%
Thoracoscopic Esophagectomy
11%
Total Gastrectomy
25%
Transhiatal
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Upfront Surgery
11%
Medicine and Dentistry
Abdominal Cancer
98%
Adipose Tissue
11%
Anastomosis Leakage
28%
Cancer Staging
12%
Cancer Surgery
13%
Cohort Analysis
26%
Comorbidity
19%
Esophageal Cancer
25%
Esophageal Cancer
23%
Esophagectomy
67%
Gastrectomy
75%
Gastrojejunostomy
11%
Hazard Ratio
28%
Logistic Regression Analysis
8%
Long Term Survival
12%
Malignant Neoplasm
26%
Maturity Onset Diabetes of the Young
11%
Minimally Invasive Procedure
6%
Mortality Rate
5%
Neoadjuvant Chemotherapy
11%
Neoadjuvant Therapy
24%
Neoplasm
7%
Odds Ratio
16%
Overall Survival
7%
Partial Gastrectomy
11%
Postoperative Complication
60%
Proportional Hazards Model
7%
Pylorus Stenosis
11%
Reoperation
19%
Retrospective Cohort Study
6%
Splenectomy
11%
Stem Cell
11%
Stenting
22%
Stomach Adenocarcinoma
29%
Surgical Anastomosis
11%
Symptomatic Treatment
13%
T-Helper Cell
11%
Thoracic Aorta
11%
Total Stomach Resection
20%
Tumor Histology
6%